Wisdomtree Biorevolution Etf Profile
| WDNA Etf | USD 16.03 0.27 1.71% |
Performance0 of 100
| Odds Of DistressLess than 9
|
WisdomTree BioRevolution is trading at 16.03 as of the 28th of November 2024, a 1.71 percent increase since the beginning of the trading day. The etf's open price was 15.76. WisdomTree BioRevolution has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for WisdomTree BioRevolution are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. More on WisdomTree BioRevolution
Moving together with WisdomTree Etf
| 0.91 | XLV | Health Care Select | PairCorr |
| 0.93 | VHT | Vanguard Health Care | PairCorr |
| 0.93 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.77 | XBI | SPDR SP Biotech | PairCorr |
| 0.89 | IXJ | iShares Global Healthcare | PairCorr |
Moving against WisdomTree Etf
WisdomTree Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Strategy ETFs, Theme ETFs, Health, WisdomTree (View all Sectors) |
| Issuer | WisdomTree |
| Inception Date | 2021-06-03 |
| Benchmark | WisdomTree BioRevolution Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 2.36 Million |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Theme |
| Market Concentration | Developed Markets |
| Region | Global |
| Administrator | State Street Bank and Trust Company |
| Advisor | WisdomTree Asset Management, Inc |
| Custodian | State Street Bank and Trust Company |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | Marlene Walker-Smith, Thomas J. Durante |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 30-Jun |
| Exchange | Cboe BZX Exchange, Inc. |
| Market Maker | Flow Traders |
| Total Expense | 0.45 |
| Management Fee | 0.45 |
| Country Name | USA |
| Returns Y T D | (6.52) |
| Name | WisdomTree BioRevolution Fund |
| Currency Code | USD |
| Open Figi | BBG0119987C0 |
| In Threey Volatility | 23.17 |
| 1y Volatility | 25.51 |
| 200 Day M A | 16.2873 |
| 50 Day M A | 15.988 |
| Code | WDNA |
| Updated At | 27th of November 2024 |
| Currency Name | US Dollar |
| In Threey Sharp Ratio | (0.75) |
| Type | ETF |
WisdomTree BioRevolution [WDNA] is traded in USA and was established 2021-06-01. The fund is listed under Health category and is part of WisdomTree family. The entity is thematically classified as Strategy ETFs. WisdomTree BioRevolution at this time have 4.54 M in net assets. , while the total return for the last 3 years was -12.8%.
Check WisdomTree BioRevolution Probability Of Bankruptcy
Sector Allocation
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on WisdomTree Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding WisdomTree Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as WisdomTree BioRevolution Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.
Top WisdomTree BioRevolution Etf Constituents
| A | Agilent Technologies | Stock | Health Care | |
| AGEN | Agenus Inc | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care | |
| DHR | Danaher | Stock | Health Care | |
| EDIT | Editas Medicine | Stock | Health Care | |
| ILMN | Illumina | Stock | Health Care | |
| LLY | Eli Lilly and | Stock | Health Care | |
| PKI | PerkinElmer | Stock | Health Care |
WisdomTree BioRevolution Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in WisdomTree BioRevolution. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Mean Deviation | 0.8854 | |||
| Standard Deviation | 1.19 | |||
| Variance | 1.42 | |||
| Risk Adjusted Performance | (0.05) |
WisdomTree BioRevolution Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. WisdomTree BioRevolution Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe WisdomTree BioRevolution price patterns.
WisdomTree BioRevolution Against Markets
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WisdomTree BioRevolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of WisdomTree BioRevolution is measured differently than its book value, which is the value of WisdomTree that is recorded on the company's balance sheet. Investors also form their own opinion of WisdomTree BioRevolution's value that differs from its market value or its book value, called intrinsic value, which is WisdomTree BioRevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WisdomTree BioRevolution's market value can be influenced by many factors that don't directly affect WisdomTree BioRevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WisdomTree BioRevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.